Application of full-genome analysis to diagnose rare monogenic disorders

Abstract Current genetic testenhancer and narrows the diagnostic intervals for rare diseases provide a diagnosis in only a modest proportion of cases. The Full-Genome Analysis method, FGA, combines long-range assembly and whole-genome sequencing to detect small variants, structural variants with bre...

Full description

Bibliographic Details
Main Authors: Joseph T. Shieh, Monica Penon-Portmann, Karen H. Y. Wong, Michal Levy-Sakin, Michelle Verghese, Anne Slavotinek, Renata C. Gallagher, Bryce A. Mendelsohn, Jessica Tenney, Daniah Beleford, Hazel Perry, Stephen K. Chow, Andrew G. Sharo, Steven E. Brenner, Zhongxia Qi, Jingwei Yu, Ophir D. Klein, David Martin, Pui-Yan Kwok, Dario Boffelli
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:npj Genomic Medicine
Online Access:https://doi.org/10.1038/s41525-021-00241-5
id doaj-9a465491e52f48439eba018a2a0c7a7a
record_format Article
spelling doaj-9a465491e52f48439eba018a2a0c7a7a2021-09-26T11:56:08ZengNature Publishing Groupnpj Genomic Medicine2056-79442021-09-016111010.1038/s41525-021-00241-5Application of full-genome analysis to diagnose rare monogenic disordersJoseph T. Shieh0Monica Penon-Portmann1Karen H. Y. Wong2Michal Levy-Sakin3Michelle Verghese4Anne Slavotinek5Renata C. Gallagher6Bryce A. Mendelsohn7Jessica Tenney8Daniah Beleford9Hazel Perry10Stephen K. Chow11Andrew G. Sharo12Steven E. Brenner13Zhongxia Qi14Jingwei Yu15Ophir D. Klein16David Martin17Pui-Yan Kwok18Dario Boffelli19Institute for Human Genetics, University of California San FranciscoInstitute for Human Genetics, University of California San FranciscoCardiovascular Research Institute, University of California San FranciscoCardiovascular Research Institute, University of California San FranciscoCardiovascular Research Institute, University of California San FranciscoInstitute for Human Genetics, University of California San FranciscoInstitute for Human Genetics, University of California San FranciscoDivision of Medical Genetics, Pediatrics, Benioff Children’s Hospital, University of California San FranciscoDivision of Medical Genetics, Pediatrics, Benioff Children’s Hospital, University of California San FranciscoDivision of Medical Genetics, Pediatrics, Benioff Children’s Hospital, University of California San FranciscoDivision of Medical Genetics, Pediatrics, Benioff Children’s Hospital, University of California San FranciscoCardiovascular Research Institute, University of California San FranciscoBiophysics Graduate Group, University of California BerkeleyDepartment of Plant and Microbial Biology, University of California BerkeleyDepartment of Laboratory Medicine, University of California San FranciscoDepartment of Laboratory Medicine, University of California San FranciscoInstitute for Human Genetics, University of California San FranciscoChildren’s Hospital Oakland Research Institute, Benioff Children’s Hospital Oakland, University of California San FranciscoInstitute for Human Genetics, University of California San FranciscoChildren’s Hospital Oakland Research Institute, Benioff Children’s Hospital Oakland, University of California San FranciscoAbstract Current genetic testenhancer and narrows the diagnostic intervals for rare diseases provide a diagnosis in only a modest proportion of cases. The Full-Genome Analysis method, FGA, combines long-range assembly and whole-genome sequencing to detect small variants, structural variants with breakpoint resolution, and phasing. We built a variant prioritization pipeline and tested FGA’s utility for diagnosis of rare diseases in a clinical setting. FGA identified structural variants and small variants with an overall diagnostic yield of 40% (20 of 50 cases) and 35% in exome-negative cases (8 of 23 cases), 4 of these were structural variants. FGA detected and mapped structural variants that are missed by short reads, including non-coding duplication, and phased variants across long distances of more than 180 kb. With the prioritization algorithm, longer DNA technologies could replace multiple tests for monogenic disorders and expand the range of variants detected. Our study suggests that genomes produced from technologies like FGA can improve variant detection and provide higher resolution genome maps for future application.https://doi.org/10.1038/s41525-021-00241-5
collection DOAJ
language English
format Article
sources DOAJ
author Joseph T. Shieh
Monica Penon-Portmann
Karen H. Y. Wong
Michal Levy-Sakin
Michelle Verghese
Anne Slavotinek
Renata C. Gallagher
Bryce A. Mendelsohn
Jessica Tenney
Daniah Beleford
Hazel Perry
Stephen K. Chow
Andrew G. Sharo
Steven E. Brenner
Zhongxia Qi
Jingwei Yu
Ophir D. Klein
David Martin
Pui-Yan Kwok
Dario Boffelli
spellingShingle Joseph T. Shieh
Monica Penon-Portmann
Karen H. Y. Wong
Michal Levy-Sakin
Michelle Verghese
Anne Slavotinek
Renata C. Gallagher
Bryce A. Mendelsohn
Jessica Tenney
Daniah Beleford
Hazel Perry
Stephen K. Chow
Andrew G. Sharo
Steven E. Brenner
Zhongxia Qi
Jingwei Yu
Ophir D. Klein
David Martin
Pui-Yan Kwok
Dario Boffelli
Application of full-genome analysis to diagnose rare monogenic disorders
npj Genomic Medicine
author_facet Joseph T. Shieh
Monica Penon-Portmann
Karen H. Y. Wong
Michal Levy-Sakin
Michelle Verghese
Anne Slavotinek
Renata C. Gallagher
Bryce A. Mendelsohn
Jessica Tenney
Daniah Beleford
Hazel Perry
Stephen K. Chow
Andrew G. Sharo
Steven E. Brenner
Zhongxia Qi
Jingwei Yu
Ophir D. Klein
David Martin
Pui-Yan Kwok
Dario Boffelli
author_sort Joseph T. Shieh
title Application of full-genome analysis to diagnose rare monogenic disorders
title_short Application of full-genome analysis to diagnose rare monogenic disorders
title_full Application of full-genome analysis to diagnose rare monogenic disorders
title_fullStr Application of full-genome analysis to diagnose rare monogenic disorders
title_full_unstemmed Application of full-genome analysis to diagnose rare monogenic disorders
title_sort application of full-genome analysis to diagnose rare monogenic disorders
publisher Nature Publishing Group
series npj Genomic Medicine
issn 2056-7944
publishDate 2021-09-01
description Abstract Current genetic testenhancer and narrows the diagnostic intervals for rare diseases provide a diagnosis in only a modest proportion of cases. The Full-Genome Analysis method, FGA, combines long-range assembly and whole-genome sequencing to detect small variants, structural variants with breakpoint resolution, and phasing. We built a variant prioritization pipeline and tested FGA’s utility for diagnosis of rare diseases in a clinical setting. FGA identified structural variants and small variants with an overall diagnostic yield of 40% (20 of 50 cases) and 35% in exome-negative cases (8 of 23 cases), 4 of these were structural variants. FGA detected and mapped structural variants that are missed by short reads, including non-coding duplication, and phased variants across long distances of more than 180 kb. With the prioritization algorithm, longer DNA technologies could replace multiple tests for monogenic disorders and expand the range of variants detected. Our study suggests that genomes produced from technologies like FGA can improve variant detection and provide higher resolution genome maps for future application.
url https://doi.org/10.1038/s41525-021-00241-5
work_keys_str_mv AT josephtshieh applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT monicapenonportmann applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT karenhywong applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT michallevysakin applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT michelleverghese applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT anneslavotinek applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT renatacgallagher applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT bryceamendelsohn applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT jessicatenney applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT daniahbeleford applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT hazelperry applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT stephenkchow applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT andrewgsharo applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT stevenebrenner applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT zhongxiaqi applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT jingweiyu applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT ophirdklein applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT davidmartin applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT puiyankwok applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
AT darioboffelli applicationoffullgenomeanalysistodiagnoseraremonogenicdisorders
_version_ 1716867643840921600